Description: AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
Home Page: www.avitamedical.com
28159 Avenue Stanford
Valencia,
CA
91355
United States
Phone:
661 367 9170
Officers
| Name | Title |
|---|---|
| Mr. James M. Corbett | CEO, President & Executive Director |
| Mr. David O'Toole | Chief Financial Officer |
| Mr. David Fencil | Senior Vice President of Global Operations |
| Dr. Katie Bush Ph.D. | Senior Vice President of Scientific & Medical Affairs |
| Ms. Jessica Ekeberg | Investor Relations Executive |
| Ms. Nicole Linda Kelsey | Chief Legal & Compliance Officer and Corporate Secretary |
| Ms. Debbie Garner | Senior Vice President of Global Marketing & Strategy |
| Mr. Rob Hall | Senior Vice President of Human Resources |
| Dr. Niraj Doshi J.D., P.M.P., Ph.D. | Senior Vice President of Product Development & Program Management |
| Mr. Ron Lagerquist | Senior Vice President of Quality Assurance & Regulatory Affairs |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 26.329 |
| Price-to-Sales TTM: | 5.1676 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 207 |